Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K H Labs

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
British Journal of Clinical Pharmacology|August 1, 1989
Drug treatment of intermittent claudicationK H Labs
VASA. Supplementum|January 1, 1991
[The value of Doppler spectral analysis for practical diagnosis]K H Labs
Circulation|May 15, 1995
Vascular training with drug therapy in peripheral arterial occlusive diseaseK H Labs, T Pischel
Methods and Findings in Experimental and Clinical Pharmacology|November 1, 1985
Drug-induced changes of the flow pulse contour recorded by directional CW-Doppler devices: a possible estimation of changes in vascular characteristic impedance and peripheral resistanceK H Labs, R Labs
VASA. Supplementum|January 1, 1991
[Value of the systolic delay time index and height-width index in comparison with pulsatility index]P Windeck, K Jäger, K H Labs
Atherosclerosis|June 1, 1997
Clinical experience with pentoxifyllineK H Labs, R Labs, M Rössner
Vascular Medicine (London, England)|January 1, 1996
The pentoxifylline experience: exercise testing reconsideredF Lindgärde, K H Labs, M Rössner
The Journal of Cardiovascular Surgery|July 1, 1987
Physiological flow variations in the periorbital arteries in Zambian Africans. A screening with bidirectional Doppler ultrasoundK H Labs, M V Govani, R Labs
Ultrasound in Medicine & Biology|January 1, 1992
How useful are acceleration- and deceleration-based Doppler indices? A trial on patients with percutaneous transluminal angioplastyP Windeck, K H Labs, K A Jaeger
VASA. Supplementum|January 1, 1991
[What does 31 phosphorus magnetic resonance spectroscopy measure?A validation in healthy probands]H Hoffmann, P Windeck, K H Labs, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
British Journal of Clinical Pharmacology|August 1, 1989
Drug treatment of intermittent claudicationK H Labs
VASA. Supplementum|January 1, 1991
[The value of Doppler spectral analysis for practical diagnosis]K H Labs
Circulation|May 15, 1995
Vascular training with drug therapy in peripheral arterial occlusive diseaseK H Labs, T Pischel
Methods and Findings in Experimental and Clinical Pharmacology|November 1, 1985
Drug-induced changes of the flow pulse contour recorded by directional CW-Doppler devices: a possible estimation of changes in vascular characteristic impedance and peripheral resistanceK H Labs, R Labs
VASA. Supplementum|January 1, 1991
[Value of the systolic delay time index and height-width index in comparison with pulsatility index]P Windeck, K Jäger, K H Labs
Atherosclerosis|June 1, 1997
Clinical experience with pentoxifyllineK H Labs, R Labs, M Rössner
Vascular Medicine (London, England)|January 1, 1996
The pentoxifylline experience: exercise testing reconsideredF Lindgärde, K H Labs, M Rössner
The Journal of Cardiovascular Surgery|July 1, 1987
Physiological flow variations in the periorbital arteries in Zambian Africans. A screening with bidirectional Doppler ultrasoundK H Labs, M V Govani, R Labs
Ultrasound in Medicine & Biology|January 1, 1992
How useful are acceleration- and deceleration-based Doppler indices? A trial on patients with percutaneous transluminal angioplastyP Windeck, K H Labs, K A Jaeger
VASA. Supplementum|January 1, 1991
[What does 31 phosphorus magnetic resonance spectroscopy measure?A validation in healthy probands]H Hoffmann, P Windeck, K H Labs, et al.
Pageof 4